HomeCompareCRBJF vs MRK

CRBJF vs MRK: Dividend Comparison 2026

CRBJF yields 4.63% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRBJF wins by $31.2K in total portfolio value
10 years
CRBJF
CRBJF
● Live price
4.63%
Share price
$3.98
Annual div
$0.18
5Y div CAGR
30.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$88.0K
Annual income
$22,716.47
Full CRBJF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CRBJF vs MRK

📍 CRBJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRBJFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRBJF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRBJF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRBJF
Annual income on $10K today (after 15% tax)
$393.88/yr
After 10yr DRIP, annual income (after tax)
$19,309.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CRBJF beats the other by $10,980.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRBJF + MRK for your $10,000?

CRBJF: 50%MRK: 50%
100% MRK50/50100% CRBJF
Portfolio after 10yr
$72.4K
Annual income
$16,257.31/yr
Blended yield
22.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CRBJF
No analyst data
Altman Z
1.6
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRBJF buys
0
MRK buys
0
No recent congressional trades found for CRBJF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRBJFMRK
Forward yield4.63%2.76%
Annual dividend / share$0.18$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR30.9%32.7%
Portfolio after 10y$88.0K$56.8K
Annual income after 10y$22,716.47$9,798.13
Total dividends collected$60.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRBJF vs MRK ($10,000, DRIP)

YearCRBJF PortfolioCRBJF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,307$606.58$11,206$366.19+$101.00CRBJF
2$12,937$839.03$12,650$502.35+$287.00CRBJF
3$15,017$1,174.45$14,407$694.19+$610.00CRBJF
4$17,736$1,667.79$16,585$967.82+$1.2KCRBJF
5$21,387$2,409.74$19,342$1,363.89+$2.0KCRBJF
6$26,439$3,554.88$22,913$1,947.19+$3.5KCRBJF
7$33,666$5,376.19$27,662$2,823.89+$6.0KCRBJF
8$44,398$8,374.81$34,159$4,173.35+$10.2KCRBJF
9$61,017$13,511.27$43,337$6,308.80+$17.7KCRBJF
10$88,005$22,716.47$56,776$9,798.13+$31.2KCRBJF

CRBJF vs MRK: Complete Analysis 2026

CRBJFStock

China Resources Land Limited, an investment holding company, invests in, develops, manages, and sells properties in the People's Republic of China. The company operates through four segments: Development Properties for Sale; Property Investments and Management; Hotel Operations; and Construction, Decoration Services, and Others. It sells residential, office, and commercial premises; leases investment properties; offers hotel accommodation and catering services; provides construction and decoration services, cultural development, and property management and related services for residential properties, urban development and operation, leasing apartment, senior housing, cinema, and others; and manufactures and sells furniture. The company is headquartered in Wanchai, Hong Kong. China Resources Land Limited is a subsidiary of CRH (Land) Limited.

Full CRBJF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CRBJF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRBJF vs SCHDCRBJF vs JEPICRBJF vs OCRBJF vs KOCRBJF vs MAINCRBJF vs JNJCRBJF vs ABBVCRBJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.